Concepedia

Melinda Mata

MM

Statistics

Publications

7

Citations

698

H-Index

7

Active since

2013

Affiliations

Baylor College of Medicine(Current)

Children's Cancer Center

Texas Children's Hospital

Methodist Hospital

Bellicum Pharmaceuticals (United States)

Melinda Mata is an author at Baylor College of Medicine specializing in cancer immunotherapy, oncology, and immunotherapy.

Publications per year

2013–2019

7

Publications

7

Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma

Sunitha Kakarla, Kevin Chow, Melinda Mata et al. · Molecular Therapy · 2013 · 338 citations · Full text

, , +17

Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models

Melinda Mata, Claudia Gerken, Phuong Nguyen et al. · Cancer Discovery · 2017 · 176 citations · Full text

, , +17

Toward Immunotherapy With Redirected T Cells in a Large Animal Model

Melinda Mata, Juan F. Vera, Claudia Gerken et al. · Journal of Immunotherapy · 2014 · 73 citations · Full text

, , +17

Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma.

Meenakshi Hegde, Christopher DeRenzo, Huimin Zhang et al. · Journal of Clinical Oncology · 2017 · 41 citations

, , +16

Abstract LB-147: Administration of HER2-CAR T cells after lymphodepletion safely improves T cell expansion and induces clinical responses in patients with advanced sarcomas

Shoba A. Navai, Christopher DeRenzo, Sujith K. Joseph et al. · Cancer Research · 2019 · 40 citations

, , +17

1–5 of 7